Recombinant HHV8 anticorps

N° du produit ABIN6937459

Détail du produit anti-HHV8 anticorps

Antigène: HHV8 (Herpes Virus Type 8 (HHV8))

Type d'anticorp: Recombinant Antibody

Reactivité: Herpes Simplex Virus (HSV)

Hôte: Souris

Clonalité: Monoclonal

Conjugué: Cet anticorp HHV8 est non-conjugé

Application: ELISA, Coating (Coat)

Purification: Purified by Protein A/G

Immunogène: Recombinant protein corresponding to the latent nuclear antigen 1 molecule of HHV8

Clone: HHV8-3606

Isotype: IgG1 kappa

Information d'application

Indications d'application:

Positive Control: Herpes simplex type 1 (HSV-1) extract or infected cells. Tissue.

Known Application: ELISA (For coating use Ab at 1-5 μg/mL, order Ab without BSA), Optimal dilution for a specific application should be determined.

Restrictions: For Research Use only

Stockage

Buffer: 10 mM PBS without BSA and without Azide.

Agent conservateur: Azide free

Stock: 4 °C,-80 °C

Stockage commentaire: Antibody with azide - store at 2 to 8°C. Antibody without azide - store at -20 to -80°C. Antibody is stable for 24 months.

Date de péremption: 24 months

Détails sur HHV8

Antigène: HHV8 (Herpes Virus Type 8 (HHV8))

Autre désignation: Human Herpes Virus 8 (HHV8) (HHV8 Produits)

Classe de substances: Virus

Sujet: HHV 8 encodes a latent nuclear antigen (LNA), which is the product of the viral gene orf 73. LNA is capable of forming a complex with retinoblastoma susceptibility gene product, which may be related to its oncogenic activity. HHV8 is associated with three different diseases observed in AIDS patients, kaposi's sarcoma, primary effusion lymphoma (which is a rare type of non-Hodgkin lymphoma affecting the body cavities) and multicentric Castleman's disease. HHV 8 is the likely etiological agent of Kaposis sarcoma.